Evercore ISI began coverage on shares of Health Catalyst (NASDAQ:HCAT) in a research note published on Monday, BenzingaRatingsTable reports. The brokerage issued an outperform rating and a $50.00 price target on the stock.

Shares of HCAT opened at $42.94 on Monday. Health Catalyst has a fifty-two week low of $36.29 and a fifty-two week high of $49.85.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Further Reading: CD Ladder

Analyst Recommendations for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.